Terms ending in 2041
Janssen Research & Development, LLC
Every in-force patent on Janssen Research & Development, LLC's record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,708,717 | Cap for an Injection Device In force · High confidence | Janssen Research & Development, LLC | In force | High confidence | |
| US 11,708,359 | Monoacylglycerol Lipase Modulators In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 12,799,203 | Method of Treating Urothelial Carcinoma with Erdafitinib and Cetrelimab In force · Medium confidence | Janssen Pharmaceutica N.V. | In force | Medium confidence | |
| US 11,512,059 | Aminocyclobutanes as Monoacylglycerol Lipase Modulators In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 11,631,395 | System and Method for Detecting Cognitive Decline Using Speech Analysis In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 11,724,035 | Injection Device with Ergonomic Housing Form Factor In force · High confidence | Janssen Pharmaceuticals, Inc. | In force | High confidence | |
| US 11,702,422 | Imidazopyridazines as Modulators of IL-17 In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 12,024,524 | Imidazopyridazines as Modulators of IL-17 In force · Medium confidence | Janssen Pharmaceutica N.V. | In force | Medium confidence | |
| US 11,691,979 | Imidazopyridazines as Modulators of IL-17 In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US 11,787,798 | Aryl Piperidines as Monoacylglycerol Lipase Modulators In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| 29 more term ends in 2041 · Pro | |||||
10 of 39 patents shown. Soonest term end first, then patent number.
Pro members see all 39.
2 of these are in force and held by Janssen Research & Development, LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.